Icelandirect Acquires SOMA LABS to Expand Pet and Human Supplement Manufacturing
March 20, 2026
Icelandirect, a U.S.-based contract manufacturer and New Heritage Capital portfolio company, acquired SOMA LABS, a New Jersey supplement manufacturer specializing in solid dosage form production. The transaction closed in February 2026 and expands Icelandirect’s capabilities into additional dosage forms, enabling broader end-to-end manufacturing for both human nutrition and pet supplement brands.
- Buyers
- Icelandirect
- Targets
- SOMA LABS
- Platforms
- Icelandirect
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
New Heritage Capital Invests in Icelandirect
August 11, 2021
Food & Beverage
Boston-based private equity firm New Heritage Capital made a platform investment in Icelandirect, a Clifton, New Jersey-based importer, manufacturer and packager of marine oils and nutraceutical products. The transaction was completed through Heritage's Private IPO structure, allowing Icelandirect's co-founders to reinvest and retain operating control while providing liquidity and capital to expand the company's ingredient offering and in-house capabilities.
-
Somafina Acquires UST Corporation
February 6, 2024
Manufacturing
Somafina, a portfolio company of Heartwood Partners, has acquired UST Corporation, a contract manufacturer of vitamins, minerals, and supplements based in Layton, Utah. The add-on expands Somafina's manufacturing capabilities across capsule, gummy, powder, and liquid formats and adds ISO-certified in-house testing and formulation expertise to support supplement brand customers.
-
Illumina Acquires SomaLogic from Standard BioTools
January 30, 2026
Healthcare Services
Illumina, Inc. completed its acquisition of SomaLogic, adding data-driven proteomics technology to expand its multiomics portfolio. The deal was for $350 million in upfront cash at closing, plus up to $75 million in near-term performance-based milestones/royalties, with Illumina expecting to fund the transaction with cash on hand.
-
CI&T Acquires Somo Global Ltd to Accelerate Growth in EMEA
January 14, 2022
IT Services
CI&T, a global digital transformation services company, entered into a sale and purchase agreement to acquire Somo Global Ltd, an award-winning digital product agency headquartered in the United Kingdom. The acquisition is intended to accelerate CI&T’s growth in EMEA and adds nearly 300 digital specialists to its regional operations.
-
Dômes Pharma Acquires SentrX Animal Care
August 16, 2023
Pharmaceuticals
Dômes Pharma has completed the acquisition of SentrX Animal Care, a Salt Lake City–based developer and manufacturer of veterinary ophthalmology and wound-care products built on its patented BioHAnce crosslinked hyaluronic acid technology. The deal expands Dômes Pharma's product capabilities in veterinary ophthalmology and establishes a stronger foothold for the French family-owned group in North America.
-
Ardena Acquires Catalent's Somerset, New Jersey Drug Product Facility
October 14, 2024
Pharmaceuticals
Ardena, a GHO Capital-backed CDMO, has signed a definitive agreement to acquire Catalent's FDA-approved drug product manufacturing facility in Somerset, New Jersey. The acquisition — expected to close in early 2025 subject to approvals — expands Ardena's US footprint and downstream capabilities in oral solid dosage manufacturing and bioanalytical services.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.